BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9341888)

  • 21. Candidate genes for multiple endocrine neoplasia type 1.
    Lagercrantz J; Larsson C; Grimmond S; Skogseid B; Gobl A; Friedman E; Carson E; Phelan C; Oberg K; Nordenskjöld M
    J Intern Med; 1995 Sep; 238(3):245-8. PubMed ID: 7673854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.
    Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 1: clinical and genetic topics.
    Marx S; Spiegel AM; Skarulis MC; Doppman JL; Collins FS; Liotta LA
    Ann Intern Med; 1998 Sep; 129(6):484-94. PubMed ID: 9735087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive diagnosis of multiple endocrine neoplasia (MEN 1) in four Australian kindreds.
    Grimmond SM; Teh BT; Hii SI; Cardinal J; Walters M; Epstein M; Edwards M; Hockey A; Pullan PT; Perry-Keene D; Boyages S; Cameron D; Hayward NK
    Aust N Z J Med; 1996 Feb; 26(1):27-32. PubMed ID: 8775525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 1 and the search for the genetic trigger.
    Farnebo F; Järhult J; Farnebo LO; Nilsson O; Teh BT; Lagercrantz J; Weber G; Sandelin K; Larsson C
    Horm Res; 1997; 47(4-6):179-84. PubMed ID: 9167950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.
    Poncin J; Abs R; Velkeniers B; Bonduelle M; Abramowicz M; Legros JJ; Verloes A; Meurisse M; Van Gaal L; Verellen C; Koulischer L; Beckers A
    Hum Mutat; 1999; 13(1):54-60. PubMed ID: 9888389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification of the gene associated with type 1 multiple endocrine neoplasia (NEM 1) susceptibility: a new pathway in the pathogenesis of neuro-endocrine tumors].
    Calender A
    Bull Cancer; 1997 Oct; 84(10):993-5. PubMed ID: 9435804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking the MEN1 gene.
    Ebrahimi SA; Sawicki MP
    Am J Surg; 1997 Sep; 174(3):266-70. PubMed ID: 9324134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated familial somatotropinomas: clinical and genetic considerations.
    Frohman LA
    Trans Am Clin Climatol Assoc; 2003; 114():165-77. PubMed ID: 12813918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
    Lloyd SE; Pang JT; Pearce SH; Leigh SE; Thakker RV
    Hum Genet; 1997 May; 99(5):585-9. PubMed ID: 9150722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [News in diagnostics and therapy of multiple endocrine neoplasia type 1].
    Starý K
    Vnitr Lek; 2015 Oct; 61(10):896-9. PubMed ID: 26486484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.
    Sakurai A; Katai M; Itakura Y; Nakajima K; Baba K; Hashizume K
    Jpn J Cancer Res; 1996 Sep; 87(9):985-94. PubMed ID: 8878463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1 presented with manic-depressive disorder: a case report with an identified MEN1 gene mutation.
    Aoki A; Tsukada T; Yasuda H; Kayashima S; Nagase T; Ito T; Suzuki T; Matsukuma S; Kuwabara N; Yoshimoto K; Yamaguchi K
    Jpn J Clin Oncol; 1997 Dec; 27(6):419-22. PubMed ID: 9438006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
    Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
    Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
    J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1.
    Weber G; Grimmond S; Lagercrantz J; Friedman E; Phelan C; Carson E; Hayward N; Jacobovitz O; Nordenskjöld M; Larsson C
    Hum Genet; 1997 Jan; 99(1):130-2. PubMed ID: 9003510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1.
    Falchetti A; Morelli A; Amorosi A; Tonelli F; Fabiani S; Martineti V; Castello R; Furlani L; Brandi ML
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2278-82. PubMed ID: 9215307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.